Bortezomib for the treatment of multiple myeloma

Kathleen Scott*, Patrick J. Hayden, Andrew Howman, Keith Wheatley, Imelda Coyne

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Citations (Scopus)


This is the protocol for a review and there is no abstract. The objectives are as follows: We will assess the effects of bortezomib treatment in comparison to other therapies, different doses, treatment administration and schedules of bortezomib, on overall survival (OS), progression-free survival (PFS), response rate (RR), health-related quality of life (HRQoL), adverse events (AE) and treatment-related death.

Original languageEnglish
Article numberCD010816
JournalCochrane Database of Systematic Reviews
Issue number11
Publication statusPublished - 11 Nov 2013

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Bortezomib for the treatment of multiple myeloma'. Together they form a unique fingerprint.

Cite this